Staff Catalogue

DIMITRIOS FARMAKIS

FARMAKIS DIMITRIOS
22895235
...
ASSOCIATE PROFESSOR
Medical School
Shiakoleion Educational Health Center (SEKY), 112
215/6 Nicosia - Limassol Old Road
 
Short Curriculum Vitae
 
Assoc. Professor Dimitriso Farmakis graduated from the Medical School of the National and Kapodistrian University of Athens and received his Doctoral Degree on haemoglobinopathy-associated heart disease from the same university in 2003. He specialized in Cardiology at Athens University Hospital “Attikon” and received his board certification in 2008. He was further trained in Cardio-Oncology at Bern University Hospital “Inselspital”, Bern, Switzerland, in Heart Failure at Zurich University Medical School, Zurich, Switzerland, and in Clinical Trials at Harvard Medical School, Boston, U.S.A., by which he was awarded a distinction.
Dr. Farmakis has worked at the National and Kapodistrian University of Athens Medical School as scientific collaborator, academic scholar, consultant cardiologist or lecturer between 1996-1997 (First Dept. of Medicine, Athens University Hospital ”Laiko”) and 2008-2017 (Heart Failure Unit, Athens University Hospital ”Attikon”). Between 2012 and 2018, he was in charge of the Cardiac Clinic for Haemoglobinopathies at Athens University Hospital ”Laiko” and since 2015, of the Cardio-Oncology Clinic at Athens University Hospital “Attikon”. In 2017, Dr. Farmakis was elected an Assistant Professor of Pathophysiology at the European University of Cyprus Medical School and in 2018, an Associate Professor of Physiology at the University of Cyprus Medical School.
His research activity has focused on heart failure, haemoglobinopathies, cardiovascular pharmacology and cardio-oncology. In total, Dr. Farmakis has published more than 220 articles, including 197 papers in international journals indexed in PubMed with a total impact factor of 1384, a total number of citations of 6655 (Google Scholar) and 5196 (Scopus) and an h index of 47 (Google Scholar) and 38 (Scopus). He has participated with abstracts in 218 international and national congresses. He has received grants for research protocols and programs and served as a primary investigator or steering committee member in research projects funded by the European Commission. He also sits on editorial boards of three international medical journals and on several scientific or advisory committees, while he serves as a reviewer for many highly-rated journals. He further served as a member of the European Society of Cardiology (ESC) guideline committee for Cardio-Oncology in 2016 and he is leading the 2019 edition of the Thalassaemia International Federation Guidelines for the management of transfusion-dependent thalassaemia.
His educational activity at the National and Kapodistrian University of Athens concerned undergraduate students of the Medical and Pharmacy Schools, postgraduate students of the Medical, Pharmacy and Nursing School and trainees in Internal Medicine and Cardiology and included Semiology and Pharmacology of the Cardiovascular System and Cardiology (2008-today). At the European University of Cyprus, he taught Physiology and Cardiology to undergraduate students of the Medical School, the School of Dentistry and the School of Sciences, while he further served as director of the basic medical sciences program “Structure & Function in Health” (2017-2018). At the University of Cyprus, he teaches Physiology and Cardiology to undergraduate students of the Medical School, while he is the director of the Phase ΙΙ program (2nd and 3rd year). He has further contributed with 67 chapters to international and Greek educational textbooks, while he has been invited as a speaker or chairman in more than 150 international and national congresses.
Dr. Farmakis is the immediate past President of the Working Group for Cardiomyopathies and Basic Research of the Hellenic Society of Cardiology, a Fellow of the European Society of Cardiology (ESC), a member of the Heart Failure Association (HFA) of the ESC, a member of the Cardio-Oncology Committee of the HFA, an ex-officio a member of the Board of the ESC Cardio-Oncology Council and a former member of the Board and Treasurer of the Hellenic College of Cardiology. Finally, Dr. Farmakis has received awards from Greek and international organizations and scientific bodies, such as the National and Kapodistrian University of Athens Medical School (first award of excellence for the doctoral thesis), the University of Patras Medical School (distinguished young cardiologist award), the Harvard Medical School (distinction for the capstone project proposal), the American Heart Association and others.
 Main research fields
 
  • Heart Failure
  • Cardio-Oncology
  • Cardiovascular complications of haemoglobinopathies
  • Clinical Pharmacology of the Cardiovascular System 
  • Clinical Trials
 
  • Farmakis D, Aessopos A. Pulmonary hypertension associated with hemoglobinopathies: Prevalent but yet overlooked. Circulation 2011;123:1227-1232.
  • Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. 2011;124:2253-2263.
  • Farmakis D, Parissis J, Filippatos G. Insights into Onco-Cardiology: atrial fibrillation. J Am Coll Cardiol 2014;63:945-953.
  • Farmakis D, Triposkiadis F, Lekakis J, Parissis J. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management. Eur J Heart Fail. 2017;19:479-489.
  • Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Hatziliami A, Joussef J, Rombos J, Loukopoulos D. Cardiac involvement in thalassemia intermedia: A multicenter study. 2001;97:3411-3416.
  • Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in β thalassemia and the sickling syndromes. 2002;99:30-35.
  • Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. 2005;127:1523-1530.
  • Aessopos A, Farmakis D, Trompoukis C, Tsironi M, Moyssakis I, Tsaftarides P, Karageorga M. Cardiac involvement in sickle beta-thalassemia. Ann Hematol. 2009;88:557-564.
  • Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, Keren A. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3:451-458.
  • Farmakis D, Parissis J, Karavidas A, Karvounis C, Triposkiadis F, Filippatos G, Lekakis J; Collaborators. In-hospital management of acute heart failure: Practical recommendations and future perspectives. Int J Cardiol. 2015;201:231-236.
  • Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J. The medical and socioeconomic burden of heart failure: A comparative delineation with cancer. Int J Cardiol. 2016;203:279-281.
  • Farmakis D, Koeck T, Mullen W, Parissis J, Gogas BD, Nikolaou M, Lekakis J, Mischak H, Filippatos G. Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates. Eur J Heart Fail. 2016;18:822-829.
  • Farmakis D, Alvarez J, Gal TB, Brito D, Fedele F, Fonseca C, Gordon AC, Gotsman I, Grossini E, Guarracino F, Harjola VP, Hellman Y, Heunks L, Ivancan V, Karavidas A, Kivikko M, Lomivorotov V, Longrois D, Masip J, Metra M, Morelli A, Nikolaou M, Papp Z, Parkhomenko A, Poelzl G, Pollesello P, Ravn HB, Rex S, Riha H, Ricksten SE, Schwinger RH, Vrtovec B, Yilmaz MB, Zielinska M, Parissis J. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. Int J Cardiol. 2016;222:303-312.
  • ESC Committee for Practice Guidelines (CPG): 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC The Task Force for cancer treatments and Committee for Practice Guidelines: cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768-2801.
  • Farmakis D, Mantzourani M, Filippatos G. Anthracycline-induced cardiomyopathy: secrets and lies. Eur J Heart Fail. 2018;20:907-909.
  • Seferović PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J, Paulus WJ, Komajda M, Cosentino F, de Boer RA, Farmakis D, Doehner W, Lambrinou E, Lopatin Y, Piepoli MF, Theodorakis MJ, Wiggers H, Lekakis J, Mebazaa A, Mamas MA, Tschöpe C, Hoes AW, Seferović JP, Logue J, McDonagh T, Riley JP, Milinković I, Polovina M, van Veldhuisen DJ, Lainscak M, Maggioni AP, Ruschitzka F, McMurray JJV. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20:853-872.
  • Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, González A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S. Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology. Eur Heart J. 2018 [Epub ahead of print].
  • Farmakis D, Keramida K, Filippatos G. How to build a cardio-oncology service? Eur J Heart Fail. 2018 [Epub ahead of print].